In order to clarify the issue, we analyzed the prospective RCT to explore the incidence and mortality of EBV and CMV infections in patients with FLT3-ITD AML with and without sorafenib maintenance post-transplantation. The gene discussed is FLT3; the disease is acute myeloid leukemia.